Congenital angiosarcoma with transient response to paclitaxel.
Angiosarcoma is a rare diagnosis with a poor prognosis. We report the first known case of congenital angiosarcoma. We also report a transient response with paclitaxel, an agent that may have a role in unresectable angiosarcoma.
Department of Pediatrics, Mayo Clinic and Foundation, Rochester, MN, USA. good@bcm.edu
Amy B
AB
Good
Antonio
A
Nascimento
Kirk M
KM
Welker
Carola A S
CA
Arndt
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D006258:Head and Neck Neoplasms / Q000151:congenital* / Q000188:drug therapy* / Q000473:pathology; D006394:Hemangiosarcoma / Q000151:congenital* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D018191:Lymphangioma, Cystic / Q000473:pathology; D017239:Paclitaxel / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel